ChronoScale Signs $7.5B AI Compute Deal, Raises $750M
ChronoScale Holdings Corporation (Nasdaq: CHRN) said on 18 November 2026 that it entered definitive agreements for a 50/50 development partnership with STN, Inc. and a financing of up to $750 million. The Odessa, Texas campus will host a large-scale AI infrastructure deployment for a leading frontier AI lab. A substantial portion of the first phase is backstopped by credit support from an investment-grade technology company and is expected to provide up to $7.5 billion in total contract value over six years. Each partner contributes $390 million in value for a 50% interest, subject to HSR clearance.
Context — Why the $7.5B AI Compute Deal Matters Now
The report frames the transaction as a step in ChronoScale's plan to become a global provider of large-scale AI infrastructure. The company said frontier AI is moving beyond incremental compute expansion toward infrastructure commitments measured in hundreds of megawatts. That framing is the catalyst: the agreement contemplates capacity across three phases, with only the first phase ordered and scheduled for deployment in the first half of calendar year 2027.
The report gives no prior-quarter comparison, so the scale has to be read from the deal structure itself. Each partner contributes $390 million in value for a 50% interest, and the first phase alone is expected to carry up to $7.5 billion in total contract value. That gap between contributed capital and contracted revenue is the core of the story.
The financing is split into $250 million in equity and an up to $500 million convertible preferred facility. Four strategic investors are participating: a leading frontier AI lab, Nutanix, Empery Digital Inc., and a storage infrastructure company. A portion of the common equity will initially be issued through a note structure held by Applied Digital Corporation, subject to conversion into underlying common shares in the fourth quarter of 2026.
The convertible preferred facility has an initial minimum conversion price of $12 per share and may be drawn over a four-year period, subject to customary draw conditions. ChronoScale expects to draw $10 million at closing, leaving the remainder as future deployment capital.
Goldman Sachs & Co. LLC is exclusive capital markets advisor and lead placement agent. Northland Capital Markets is co-placement agent. Lake Street Capital Markets and B. Riley Securities are senior financial advisors, with Lucid Capital Markets and Needham & Company as financial advisors.
Data — What the Numbers Show
The headline figures are the $7.5 billion total contract value, the $750 million financing, the $390 million contributed by each partner, and the $20.8 million blended annual revenue per megawatt across all three phases. The first 65 MW is scheduled to be completed on the deployment schedule, with the company holding a right of first offer on the remaining 285 MW for phases two and three.
| Item | Figure |
|---|---|
| Total contract value (first phase) | Up to $7.5B over six years |
| Financing | Up to $750M ($250M equity + up to $500M preferred) |
| Each partner contribution | $390M for 50% interest |
| Blended annual revenue per MW | $20.8M across three phases |
| First phase capacity | 65 MW, deployment H1 2027 |
| Convertible preferred floor | $12 per share |
Before the deal, ChronoScale's contribution funding was limited to the proceeds of its common equity financing for the initial portion only. After the deal, the balance is to be funded from cash on hand, other existing capital sources, and/or future project financing. The company did not disclose the total project cost or the specific draw schedule beyond the $10 million initial draw.
The report names no peer comparison and no sector benchmark. The $20.8 million annual revenue per megawatt figure is the only unit-economics metric given, and it is blended across phases whose GPU configurations vary. The report does not break out revenue per megawatt by phase.
Analysis — What It Means for AI Infrastructure Markets
The second-order read is in the supply chain. A 65 MW first phase with a right of first offer on 285 MW more pulls in storage, power, and interconnect vendors. Nutanix and a storage infrastructure company are on the cap table, which signals where the company expects hardware bottlenecks. Empery Digital's participation points to the digital-infrastructure investor base.
The risk is concentration. The credit support comes from one investment-grade technology company, and the customer is one frontier AI lab. The company's own risk disclosure states the customer has no commitment to order phases two or three, and without those orders the partnership's total contract value will be substantially lower. That single sentence is the biggest caveat in the release.
The counter-argument is that backstop credit support from an investment-grade counterparty materially de-risks phase one. If the backstop holds, the $7.5 billion TCV is closer to contracted revenue than to a pipeline figure. If it does not, the deal is a 65 MW build with an option on 285 MW.
Positioning is likely to split. Infrastructure and AI-thematic funds have a reason to look at CHRN as a pure-play compute platform with a named frontier-lab customer. Credit-focused investors will focus on the convertible preferred floor at $12 per share and the four-year draw window. The company said the equity financing supports its phased deployment strategy, while the preferred facility is intended to provide financial flexibility.
Outlook — What to Watch Next
The first catalyst is closing. The partnership and the financing are each expected to close on 18 November 2026, subject to satisfaction or waiver of closing conditions. HSR clearance is required for the partnership.
The second is the Q4 2026 conversion of the Applied Digital note into underlying common equity. That conversion changes the share count and is the clearest near-term dilution event the report names.
The third is the first-phase deployment in the first half of 2027. Any slippage in the 65 MW schedule would push revenue recognition on the $7.5 billion TCV.
On levels, the report names one: the $12 per share initial minimum conversion price on the convertible preferred. That is the only price the company disclosed, and it functions as a reference point for the preferred holders' economics. The report gives no share price, market cap, or trading level for CHRN.
Frequently Asked Questions
What does the ChronoScale deal mean for retail investors in CHRN?
The report does not give a share price, market cap, or float, so no valuation read is possible from the release alone. What it does give is dilution mechanics: a $250 million equity component, a note convertible into common shares in Q4 2026, and up to $500 million in convertible preferred with a $12 minimum conversion price. Retail holders should track the Q4 conversion and any preferred draws as share-count events.
What happens if the frontier AI lab does not order phases two and three?
The company's own risk language is direct: the customer has no commitment to order phases two or three, and without those orders the partnership's total contract value will be substantially lower. Only the first phase, 65 MW, is ordered and scheduled for the first half of 2027. The remaining 285 MW depends on the company exercising its right of first offer and reaching agreement on terms, land, permits, power, and financing.
Why is the revenue per megawatt figure given on a blended basis?
The report states GPU configurations vary by phase, so the company blended the economics across all three phases to produce the $20.8 million annual revenue per megawatt figure. That means the metric is not a per-phase run rate and should not be applied to the confirmed 65 MW alone. The report does not disclose phase-level revenue per megawatt, so the mix between training and inference economics across phases is not visible.
PartnerPosition yourself for the macro moves discussed above
Start TradingSponsored
Ready to trade the markets?
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.